Ken Griffin Danaher Corp Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$224.58 - $256.19 $6.15 Million - $7.02 Million	27,400 Added 5.32%	542,400 $135 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $6.35 Million - $8 Million	34,300 Added 7.14%	515,000 $119 Million
Q3 2023 Nov 14, 2023	BUY	$233.08 - $265.59 $2.35 Million - $2.68 Million	10,100 Added 2.15%	480,700 $119 Million
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $30 Million - $34.1 Million	133,200 Added 39.48%	470,600 $113 Million
Q1 2023 May 15, 2023	SELL	$239.75 - $277.0 $37.2 Million - $43 Million	-155,200 Reduced 31.51%	337,400 $85 Million

Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $51 Million - $59.6 Million	-211,300 Reduced 30.02%	492,600 $131 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $31.6 Million - $193 Million	127,800 Added 22.18%	703,900 $182 Million

2,371

559M

3.54M

3.99M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $182B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.